Results 1 to 10 of about 5,575,329 (338)

Fluoroquinolone antibiotics and adverse events [PDF]

Australian Prescriber, 2021
SUMMARY Fluoroquinolones are broad-spectrum antibiotics with good oral bioavailability. They are used for the treatment of a wide variety of infections, but there are restrictions on prescribing these drugs.
Diva Baggio, M. Ananda-Rajah
semanticscholar   +4 more sources

Minor Adverse Events Postcolonoscopy [PDF]

Canadian Journal of Gastroenterology and Hepatology, 2014
In recent years, the Canadian Journal of Gastroenterology and Hepatology has provided its readership with multiple publications to further our understanding of what constitutes a high-quality procedure as well as a desirable colonoscopy experience (1–4).
Catherine Dubé
doaj   +3 more sources

Adverse Events of DOACs in Children

Frontiers in Pediatrics, 2022
Venous thromboembolism (VTE) has an increasing rate of significance in pediatric patients. The currently standardized anticoagulants (unfractionated heparin, low molecular weight heparin and vitamin K antagonists) and their dose regimens were not ...
Alessandra Bosch, Manuela Albisetti, Manuela Albisetti   +2 more
doaj   +3 more sources

Evaluating adverse events in databases

Pharmacology Research & Perspectives, 2023
Katie Lovell, Steven R. Feldman
doaj   +3 more sources

Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss.

Journal of the American Medical Association (JAMA), 2023
This database study examines the association between glucagon-like peptide 1 agonists (eg, semaglutide, liraglutide) used for weight loss and reports of gastrointestinal adverse events.
M. Sodhi, Ramin Rezaeianzadeh, Abbas Kezouh, M. Etminan   +3 more
semanticscholar   +1 more source

High-Antimicrobial Gallium-Doped Zinc Oxide Thin Films on Bio-Based Poly(Ethylene Furanoate) Substrates for Food Packaging Application

Membranes, 2023
Thin films of gallium-doped zinc oxide (GZO), with a thickness of around fifty nanometers were deposited on bio-based poly(ethylene furanoate) (PEF) substrates by radio-frequency sputtering.
Chaoting Zhu, Danling Ye, Tianqi Zhou, Yashuang Cui, Jianbing Yin   +4 more
doaj   +1 more source

Immune-related adverse events of immune checkpoint inhibitors: a review

Frontiers in Immunology, 2023
Since the first Immune Checkpoint Inhibitor was developed, tumor immunotherapy has entered a new era, and the response rate and survival rate of many cancers have also been improved.
Qinan Yin, Liuyun Wu, Lizhu Han, Xingyue Zheng, Rongsheng Tong, Lianlian Li, Lan Bai, Y. Bian   +7 more
semanticscholar   +1 more source

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update

Journal of Clinical Oncology, 2021
PURPOSE To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitor (ICPi) therapy. METHODS A multidisciplinary panel of medical
B. Schneider, J. Naidoo, B. Santomasso, C. Lacchetti, S. Adkins, M. Anadkat, M. Atkins, Kelly J. Brassil, J. Caterino, I. Chau, M. Davies, M. Ernstoff, L. Fecher, M. Ghosh, I. Jaiyesimi, J. Mammen, A. Naing, L. Nastoupil, T. Phillips, Laura D. Porter, C. Reichner, Carole Seigel, Jung-Min Song, A. Spira, M. Suarez‐Almazor, U. Swami, John A Thompson, Praveen Vikas, Yinghong Wang, J. Weber, P. Funchain, Kathryn Bollin   +31 more
semanticscholar   +1 more source

Adverse Events Related to Tirzepatide

Journal of the Endocrine Society, 2023
Context Tirzepatide is a dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA) approved by the US Food and Drug Administration in May 2022 for patients with type 2 diabetes mellitus (T2DM).
Rahul Mishra, Rishi Raj, Ghada Elshimy, I. Zapata, Lakshmi Kannan, Priyanka Majety, Dinesh Edem, Ricardo Correa   +7 more
semanticscholar   +1 more source

Adverse events: an expensive and avoidable hospital problem

Annals of Medicine, 2022
Introduction Adverse healthcare-related events (AE) entail reduced patient safety. Estimating their frequency, characteristics, avoidability and impact is a means to identify targets for improvement in the quality of care.Methods This was a descriptive ...
Diego San Jose-Saras, José L. Valencia-Martín, Jorge Vicente-Guijarro, Paloma Moreno-Nunez, Alberto Pardo-Hernández, Jesús M. Aranaz-Andres   +5 more
doaj   +1 more source